V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007346 | 220002882 | 1.68 | 48.9 | Palliative (P) | 2014-05-01 | 2014-05-07 | CARBOPLATIN + PACLITAXEL | N | N | 220032224 | CARBOPLATIN + PACLITAXEL |
| 220007347 | 220002883 | 1.62 | 55.5 | null | 2015-08-26 | 2015-08-27 | AML18 PILOT TRIAL | Y | N | 220032225 | PILOT TRIAL |
| 220007348 | 220002884 | 1.6 | 56 | Curative (C) | 2014-08-01 | 2014-08-01 | AML16 DA 3+10 | N | N | 220032227 | AML16 TRIAL |
| 220007349 | 220002885 | 1.75 | 77.9 | null | 2017-10-06 | 2017-10-19 | GemCarbo Days 1+8 | N | N | 220032228 | GEMCARBO |
| 220007350 | 220002885 | 0 | 75.9 | Palliative (P) | 2015-03-14 | 2015-03-17 | CISPLATIN + GEMCITABINE | 2 | N | 220032228 | CISPLATIN + GEMCITABINE |
| 220007351 | 220002885 | null | 79.7 | Curative (C) | 2017-04-13 | 2017-05-17 | CARBOPLATIN + PACLITAXEL | N | N | 220032228 | CARBOPLATIN + PACLITAXEL |
| 220007352 | 220002886 | null | null | Palliative (P) | 2015-11-01 | 2015-11-07 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220032236 | CISPLATIN + GEMCITABINE |
| 220007353 | 220002887 | 1.78 | 111.8 | Disease modification (D) | 2017-12-07 | 2017-12-08 | Dasatinib | 2 | N | 220032240 | DASATINIB |
| 220007354 | 220002887 | 1.74 | null | Curative (C) | 2017-02-27 | 2017-03-01 | AML 18 TRIAL | 01 | N | 220032240 | AML18 TRIAL |
| 220007355 | 220002888 | 1.7 | 94.95 | Curative (C) | null | 2015-09-15 | AML 18 TRIAL | 1 | N | 220032247 | AML18 TRIAL |
| 220007356 | 220002889 | 1.72 | null | Curative (C) | 2013-05-23 | 2013-05-24 | AML 18 TRIAL | 01 | N | 220032248 | AML18 TRIAL |
| 220007357 | 220002890 | null | 83.25 | Palliative (P) | 2015-05-16 | 2015-05-21 | GemCarbo Days 1+8 | N | N | 220032249 | GEMCARBO |
| 220007358 | 220002891 | 1.73 | 92.8 | Curative (C) | 2015-07-31 | 2015-08-01 | Idarubicin+Tretinoin Spanish Crse2 | null | N | 220032251 | IDARUBICIN + TRETINOIN |
| 220007359 | 220002892 | 1.68 | 78.4 | Palliative (P) | 2014-08-07 | 2014-08-31 | CARBOPLATIN + PACLITAXEL | 2 | N | 220032252 | CARBOPLATIN + PACLITAXEL |
| 220007360 | 220002893 | 1.55 | 69.6 | Curative (C) | null | 2017-10-18 | AML16 DA 3+10 | N | N | 220032253 | AML16 TRIAL |
| 220007361 | 220002893 | null | 49.8 | null | 2017-01-15 | 2017-01-23 | AML16 DA 3+10 | Y | N | 220032253 | AML16 TRIAL |
| 220007362 | 220002893 | 1.53 | 71.45 | null | 2014-02-28 | 2014-03-02 | AML 18 TRIAL | 01 | N | 220032253 | AML18 TRIAL |
| 220007364 | 220011636 | 1.82 | 70 | Palliative (P) | 2016-10-13 | 2016-10-21 | GemCarbo Days 1+8 | 02 | N | 220032260 | GEMCARBO |
| 220007365 | 220002895 | 1.16 | 76.2 | Palliative (P) | 2015-06-26 | 2015-06-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032262 | CARBOPLATIN + PACLITAXEL |
| 220007367 | 220002897 | null | 85.1 | Disease modification (D) | 2015-08-25 | 2015-08-25 | Dasatinib | null | N | 220032264 | DASATINIB |
| 220007368 | 220002898 | 1.6 | 14.7 | Curative (C) | 2013-04-14 | 2013-04-14 | AML18 PILOT TRIAL | Y | N | 220032265 | PILOT TRIAL |
| 220007369 | 220002898 | 1.81 | 77.9 | Curative (C) | 2013-11-21 | 2013-12-27 | CARBOPLATIN + PACLITAXEL | N | null | 220032265 | CARBOPLATIN + PACLITAXEL |
| 220007370 | 220016261 | 1.69 | 76 | Palliative (P) | 2016-07-28 | 2016-09-10 | CISPLATIN + GEMCITABINE | 2 | N | 220032269 | CISPLATIN + GEMCITABINE |
| 220007371 | 220016261 | 1.62 | 64.8 | Curative (C) | 2015-11-17 | 2015-11-18 | AML18 PILOT TRIAL | Y | N | 220032269 | PILOT TRIAL |
| 220007372 | 220016261 | 1.65 | null | Curative (C) | 2013-04-29 | 2013-04-29 | AML18 PILOT TRIAL | Y | N | 220032269 | PILOT TRIAL |
| 220007373 | 220016261 | null | 98.9 | Palliative (P) | 2018-01-27 | 2018-02-01 | CARBOPLATIN + GEMCITABINE | N | null | 220032269 | GEMCARBO |
| 220007374 | 220016261 | 1.76 | 86.5 | Curative (C) | null | 2013-06-04 | Idarubicin+Tretinoin Spanish Crse4 | Y | N | 220032269 | IDARUBICIN + TRETINOIN |
| 220007377 | 220002901 | -1 | 78.3 | Curative (C) | 2017-06-23 | 2017-06-26 | AML 18 Pilot Trial | Y | N | 220032286 | PILOT TRIAL |
| 220007378 | 220002901 | 0 | null | Curative (C) | 2016-02-21 | 2016-02-24 | IDARUBICIN + TRETINOIN | N | N | 220032286 | IDARUBICIN + TRETINOIN |
| 220007379 | 220002902 | 1.47 | 97.5 | Palliative (P) | 2015-06-01 | 2015-06-01 | IDARUBICIN + TRETINOIN | 2 | N | 220032288 | IDARUBICIN + TRETINOIN |
| 220007380 | 220002902 | 1.82 | 83.4 | Curative (C) | 2014-03-12 | 2014-02-12 | CARBOPLATIN + PACLITAXEL | null | N | 220032288 | CARBOPLATIN + PACLITAXEL |
| 220007381 | 220002903 | null | 92 | Curative (C) | 2014-03-24 | 2014-04-02 | Idarubicin+Tretinoin Spanish Crse1 | 02 | null | 220032293 | IDARUBICIN + TRETINOIN |
| 220007382 | 220002903 | null | 81.8 | Neo-adjuvant (N) | 2016-06-23 | 2016-06-24 | Dasatinib | 2 | N | 220032293 | DASATINIB |
| 220007383 | 220002903 | 1.83 | 109 | Palliative (P) | 2015-03-25 | 2015-03-25 | CISPLATIN + GEMCITABINE | N | null | 220032293 | CISPLATIN + GEMCITABINE |
| 220007384 | 220002903 | 1.71 | 79 | Palliative (P) | 2013-12-03 | 2013-12-26 | Carboplatin + Paclitaxel (weekly) | 2 | N | 220032293 | CARBOPLATIN + PACLITAXEL |
| 220007385 | 220002903 | null | null | Curative (C) | null | 2014-10-31 | AML16 Low Dose Cytarabine | N | N | 220032293 | AML16 TRIAL |
| 220007386 | 220002904 | 1.44 | 69 | Curative (C) | 2013-09-10 | 2013-09-15 | Dasatinib | 02 | N | 220032308 | DASATINIB |
| 220007387 | 220002904 | null | null | Palliative (P) | 2015-09-01 | 2015-09-07 | CISPLATIN + GEMCITABINE | 2 | N | 220032308 | CISPLATIN + GEMCITABINE |
| 220007388 | 220002904 | 1.73 | 99 | Palliative (P) | 2014-07-07 | 2014-07-08 | CARBOPLATIN + PACLITAXEL | N | Y | 220032308 | CARBOPLATIN + PACLITAXEL |
| 220007389 | 220002904 | 1.68 | 74.8 | null | 2017-10-18 | 2017-10-23 | Cisplatin+Gemcitabine (gallbladder) | 2 | null | 220032308 | CISPLATIN + GEMCITABINE |
| 220007390 | 220020418 | null | 79 | Curative (C) | 2017-10-16 | 2017-10-17 | AML 18 TRIAL | Y | null | 220032316 | AML18 TRIAL |
| 220007391 | 220020418 | 1.84 | 80.2 | Curative (C) | 2015-02-28 | 2015-03-01 | Dasatinib | N | N | 220032316 | DASATINIB |
| 220007392 | 220020418 | null | 71.95 | Curative (C) | 2016-09-26 | 2016-09-27 | AML 18 TRIAL | Y | null | 220032316 | AML18 TRIAL |
| 220007393 | 220020418 | 1.62 | 104.8 | Disease modification (D) | null | 2016-09-15 | AML16 Low Dose Cytarabine | Y | N | 220032316 | AML16 TRIAL |
| 220007394 | 220002905 | 1.65 | 68.3 | Palliative (P) | 2013-06-11 | 2013-06-17 | CARBOPLATIN + PACLITAXEL | N | N | 220032320 | CARBOPLATIN + PACLITAXEL |
| 220007395 | 220002906 | 1.63 | 53 | Palliative (P) | 2015-07-29 | 2015-07-29 | CISPLATIN + GEMCITABINE | N | N | 220032322 | CISPLATIN + GEMCITABINE |
| 220007396 | 220002906 | null | 125 | Neo-adjuvant (N) | 2014-01-17 | 2014-01-23 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032322 | CARBOPLATIN + PACLITAXEL |
| 220007397 | 220002907 | 1.64 | 78.8 | Disease modification (D) | 2017-02-10 | 2017-02-10 | Dasatinib | N | N | 220032325 | DASATINIB |
| 220007398 | 220002908 | 1.56 | null | Palliative (P) | 2017-05-22 | 2017-05-29 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220032326 | CISPLATIN + GEMCITABINE |
| 220007400 | 220002910 | null | 74 | Curative (C) | 2014-07-04 | 2014-07-10 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220032328 | CARBOPLATIN + PACLITAXEL |